<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Minding The Pharm &#187; verdicts</title>
	<atom:link href="http://seelielaw.com/pharm/tag/verdicts/feed/" rel="self" type="application/rss+xml" />
	<link>http://seelielaw.com/pharm</link>
	<description>Current Issues in the Drug Industry</description>
	<lastBuildDate>Sat, 10 Jul 2010 12:22:18 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.4</generator>
		<item>
		<title>Mont. Jury Awards $3.2M In 1st Zometa Jaw Injury Case To Go To Verdict</title>
		<link>http://seelielaw.com/pharm/2009/11/02/mont-jury-awards-32m-in-1st-zometa-jaw-injury-case-to-go-to-verdict/</link>
		<comments>http://seelielaw.com/pharm/2009/11/02/mont-jury-awards-32m-in-1st-zometa-jaw-injury-case-to-go-to-verdict/#comments</comments>
		<pubDate>Tue, 03 Nov 2009 00:48:47 +0000</pubDate>
		<dc:creator>Bsee</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[verdicts]]></category>

		<guid isPermaLink="false">http://seelielaw.com/pharm/?p=18</guid>
		<description><![CDATA[In the first bisphosphonate case to go to verdict, a Montana state court jury on Oct. 21 awarded a plaintiff $3.2 million after finding that Novartis Pharmaceuticals Corp. was negligent in failing to warn her doctors of the risks of its Zometa bone-loss prevention drug and causing her osteonecrosis of the jaw (ONJ) (Peggy L. [...]]]></description>
			<content:encoded><![CDATA[<p>In the first bisphosphonate case to go to verdict, a Montana state court jury on Oct. 21 awarded a plaintiff $3.2 million after finding that Novartis Pharmaceuticals Corp. was negligent in failing to warn her doctors of the risks of its Zometa bone-loss prevention drug and causing her osteonecrosis of the jaw (ONJ) (Peggy L. Stevens v. Novartis Pharmaceuticals Corporation, No. DV-08-100, Mont. Dist., 4th Dist., Missoula Co.).</p>
]]></content:encoded>
			<wfw:commentRss>http://seelielaw.com/pharm/2009/11/02/mont-jury-awards-32m-in-1st-zometa-jaw-injury-case-to-go-to-verdict/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

